Skip to main content
. Author manuscript; available in PMC: 2017 Apr 6.
Published in final edited form as: Adv Clin Chem. 2016 Apr 7;74:103–141. doi: 10.1016/bs.acc.2015.12.005

Figure 8.

Figure 8

Tumor-derived exosomes in drug resistance. Resistance of tumor cells to chemotherapy may be mediated by exosomes. Cisplatin-sensitive tumor cells die and, as a result, levels of tumor-derived exosomes decrease in plasma. In contrast, cisplatin-resistant tumor cells package the drug into exosomes and export large quantities of exosomes out of the cell. Thus, the exosomal content of plasma increases.